Based on the measurements of operating efficiency obtained from InMode's historical financial statements, InMode may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. At present, InMode's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Net Tangible Assets is expected to grow to about 669.7 M, whereas Total Current Liabilities is forecasted to decline to about 47.1 M. Key indicators impacting InMode's financial strength include:
The financial analysis of InMode is a critical element in measuring its lifeblood. Investors should not minimize InMode's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Understanding current and past InMode Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of InMode's financial statements are interrelated, with each one affecting the others. For example, an increase in InMode's assets may result in an increase in income on the income statement.
Please note, the presentation of InMode's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, InMode's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of InMode's management manipulating its earnings.
InMode Stock Summary
InMode competes with Tandem Diabetes, Iradimed, Axogen, Integra LifeSciences, and Claritev. InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel. Inmode operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 362 people.
Comparative valuation techniques use various fundamental indicators to help in determining InMode's current stock value. Our valuation model uses many indicators to compare InMode value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across InMode competition to find correlations between indicators driving InMode's intrinsic value. More Info.
InMode is rated second overall in return on equity category among its peers. It also is rated second overall in return on asset category among its peers reporting about 0.33 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for InMode is roughly 3.07 . At present, InMode's Return On Equity is projected to increase slightly based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value InMode by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
InMode Systematic Risk
InMode's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. InMode volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on InMode correlated with the market. If Beta is less than 0 InMode generally moves in the opposite direction as compared to the market. If InMode Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one InMode is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of InMode is generally in the same direction as the market. If Beta > 1 InMode moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in InMode Stock are looking for potential investment opportunities by analyzing not only static indicators but also various InMode's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of InMode growth as a starting point in their analysis.
Price Earnings To Growth Ratio
(2.61)
At present, InMode's Price Earnings To Growth Ratio is projected to slightly decrease based on the last few years of reporting.
InMode January 6, 2026 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of InMode help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of InMode. We use our internally-developed statistical techniques to arrive at the intrinsic value of InMode based on widely used predictive technical indicators. In general, we focus on analyzing InMode Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build InMode's daily price indicators and compare them against related drivers.
When running InMode's price analysis, check to measure InMode's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InMode is operating at the current time. Most of InMode's value examination focuses on studying past and present price action to predict the probability of InMode's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InMode's price. Additionally, you may evaluate how the addition of InMode to your portfolios can decrease your overall portfolio volatility.